If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Euro. Regulatory News (JEGI)

Share Price Information for Jpmorgan Euro. (JEGI)

Share Price is delayed by 15 minutes
Get Live Data
149.00    -0.80 (-0.53%)
Bid:
148.20
Ask:
149.00
Spread: 0.80 (0.54%)
Market Cap: £629.33m
JEGI Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Euro. Share Chart

Initiation note from QuotedData

7 Jul 2026 15:09

RNS Number : 3725L
JPMorgan European Grwth & Inc PLC
07 July 2026
 

JPMorgan European Growth and Income - Initiation note from QuotedData

7 July 2026

It's a rollover

JPMorgan European Growth and Income (JEGI) has been chosen as the default rollover option for the proposed reconstruction of European Opportunities Trust (EOT). JEGI investors will already be aware that the trust has the best long-term track record within its peer group. Any assets that rollover from EOT will help improve liquidity in JEGI's shares and lower its ongoing running costs per share. For an EOT investor, there are the added benefits of a much higher dividend income, better track record of keeping the discount tight, and JEGI's more diversified, risk conscious investment approach.

Full Research:

https://quoteddata.com/research/jpmorgan-european-growth-and-income-its-a-rollover-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note JPMorgan European Growth and Income Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBRSRNBUBRAR
Date   Source Headline
16th Dec 202410:57 amRNSNet Asset Value(s)
13th Dec 202410:51 amRNSNet Asset Value(s)
12th Dec 202410:21 amRNSNet Asset Value(s)
11th Dec 20243:21 pmRNSTen Largest Investments
11th Dec 202411:10 amRNSNet Asset Value(s)
10th Dec 202410:43 amRNSNet Asset Value(s)
9th Dec 20245:12 pmRNSTransaction in Own Shares
9th Dec 202412:17 pmRNSGearing Announcement
9th Dec 202410:43 amRNSNet Asset Value(s)
6th Dec 202411:25 amRNSNet Asset Value(s)
5th Dec 202410:26 amRNSNet Asset Value(s)
4th Dec 202410:33 amRNSNet Asset Value(s)
3rd Dec 20245:12 pmRNSTransaction in Own Shares
3rd Dec 202410:45 amRNSNet Asset Value(s)
2nd Dec 20245:13 pmRNSTransaction in Own Shares
2nd Dec 20241:19 pmRNSGearing announcement
2nd Dec 202412:16 pmRNSNet Asset Value(s)
2nd Dec 202410:38 amRNSTotal Voting Rights
29th Nov 202410:54 amRNSNet Asset Value(s)
28th Nov 202411:56 amRNSNet Asset Value(s)
27th Nov 20242:00 pmRNSHalf-year Report
27th Nov 202411:19 amRNSNet Asset Value(s)
26th Nov 20245:16 pmRNSTransaction in Own Shares
26th Nov 202411:12 amRNSNet Asset Value(s)
25th Nov 20245:15 pmRNSTransaction in Own Shares
25th Nov 20244:18 pmRNSHolding(s) in Company
25th Nov 202411:27 amRNSGearing announcement
25th Nov 202410:53 amRNSNet Asset Value(s)
22nd Nov 202411:37 amRNSNet Asset Value(s)
21st Nov 20245:08 pmRNSTransaction in Own Shares
21st Nov 20244:50 pmRNSDividend Declaration
21st Nov 202411:38 amRNSNet Asset Value(s)
20th Nov 20245:03 pmRNSTransaction in Own Shares
20th Nov 202410:55 amRNSNet Asset Value(s)
19th Nov 202411:07 amRNSNet Asset Value(s)
18th Nov 20245:09 pmRNSTransaction in Own Shares
18th Nov 202412:15 pmRNSGearing announcement
18th Nov 202411:51 amRNSNet Asset Value(s)
15th Nov 202411:05 amRNSNet Asset Value(s)
14th Nov 20245:06 pmRNSTransaction in Own Shares
14th Nov 202410:55 amRNSNet Asset Value(s)
13th Nov 202410:45 amRNSNet Asset Value(s)
12th Nov 202411:16 amRNSNet Asset Value(s)
11th Nov 20245:11 pmRNSTransaction in Own Shares
11th Nov 20244:02 pmRNSTen Largest Investments
11th Nov 20241:34 pmRNSGearing announcement
11th Nov 202411:09 amRNSNet Asset Value(s)
8th Nov 202411:43 amRNSNet Asset Value(s)
7th Nov 20245:14 pmRNSTransaction in Own Shares
7th Nov 202411:10 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.